Contents
Download PDF
pdf Download XML
242 Views
94 Downloads
Share this article
Research Article | Volume:1 Issue 3 (, 2011) | Pages 41 - 50
Effective Lipid-lowering Therapy in High-risk Patients
Under a Creative Commons license
Open Access
Published
Sept. 25, 2010
Abstract
Cardiovascular disease (CVD) is the primary cause of mortality in developed and developing societies. Identifying patients at high CVD risk is important but challenging. Measurement of classical risk factors is crucial for this assessment. Also, next to traditional factors such as lipids or lipoprotein levels, apolipoproteins or Lp(a) plasma levels may be important for such purposes. Moreover, the use of emerging biomarkers such as C-reactive protein is likely to gain importance in upcoming years in an attempt to better identify subgroups of patients that may be at increased cardiovascular risk. Our review will focus on novel tools that are, or will become available to identify patients at high CVD risk; and to discuss the potential usefulness of statins in these patients, with a particular focus on potent statin therapy.
Keywords
Recommended Articles
Research Article
Assessment of Nutritional Risk Using Nutric Score and Outcomes in Mechanically Ventilated Patients
Published: 15/09/2025
Download PDF
Research Article
Prevalence of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Cross-Sectional Echocardiographic Study
...
Published: 15/09/2024
Download PDF
Research Article
Assessment of Myocardial Viability by Cardiac Magnetic Resonance Imaging.
...
Published: 17/09/2025
Download PDF
Research Article
A study of Alvarado score and USG in Diagnosis of Acute Appendicitis at Tertiary Hospital in Central India.
...
Published: 17/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.